Provided by Tiger Trade Technology Pte. Ltd.

Tredegar

7.03
+0.08001.15%
Post-market: 7.030.00000.00%19:30 EDT
Volume:176.63K
Turnover:1.24M
Market Cap:245.42M
PE:7.34
High:7.06
Open:7.05
Low:6.96
Close:6.95
52wk High:10.53
52wk Low:6.25
Shares:34.91M
Float Shares:28.20M
Volume Ratio:1.12
T/O Rate:0.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9572
EPS(LYR):0.9604
ROE:15.47%
ROA:6.50%
PB:1.07
PE(LYR):7.32

Loading ...

TG Metals Seeks ASX Quotation for Nearly 15 Million New Shares

TIPRANKS
·
Aug 10

Tredegar Shares Gain on Higher 2Q Profit, Aluminum Margin Tailwinds

Dow Jones
·
Aug 08

Tredegar Q2 Revenue Rises on Aluminum Extrusions Margin Gains

Reuters
·
Aug 07

Tredegar reports Q2 EPS ex-items 18c vs. 5c last year

TIPRANKS
·
Aug 07

Tredegar Q2 FY26 Net Income Rises to $6.02 Million; Sales Climbs 20.73% to $216.24 Million

Reuters
·
Aug 07

Tredegar Q2 Adj. EPS $0.18 Up From $0.05 YoY, Sales $209.764M Up From $172.963M YoY

Benzinga Earnings
·
Aug 07

Tredegar Corp: Tariffs and Duties Continue to be Passed Through to Customers Under Company's Metal‑Cost Adjustment Mechanism

THOMSON REUTERS
·
Aug 07

Tredegar Corp: Implemented Additional Price Increases in Q1 of 2026 and Q3 of 2025 to Offset Tariff‑Related Costs

THOMSON REUTERS
·
Aug 07

Tredegar Q2 Net Income from Cont Ops USD 6.4 Million

THOMSON REUTERS
·
Aug 07

Tredegar Q2 EPS USD 0.17

THOMSON REUTERS
·
Aug 07

Tredegar Reports Second Quarter 2026 Results

THOMSON REUTERS
·
Aug 07

TG Therapeutics price target raised to $21 from $20 at BofA

TIPRANKS
·
Aug 06

TG Therapeutics (TGTX) Looks Fairly Valued After Raised 2026 Guidance And Mixed Q2 Earnings

Simply Wall St.
·
Aug 06

Analysts Offer Insights on Healthcare Companies: TG Therapeutics (TGTX), Syndax Pharmaceuticals (SNDX) and DaVita (DVA)

TIPRANKS
·
Aug 05

TG Therapeutics Earnings Call Signals BRIUMVI Surge

TIPRANKS
·
Aug 05

TG Metals Plans Share and Option Issue to Bolster Capital Base

TIPRANKS
·
Aug 04

TG Metals raises A$2.5 million to drive gold and lithium project development

TIPRANKS
·
Aug 04

TG Therapeutics Down over 11%, on Pace for Largest Percent Decrease Since August 2025

Dow Jones
·
Aug 04

TG Therapeutics falls -10.6%

TIPRANKS
·
Aug 04

Press Release: Tredegar Plans to Release Second Quarter 2026 Financial Results on August 7, 2026

Dow Jones
·
Aug 03